Viewing Study NCT00772694


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-24 @ 12:25 AM
Study NCT ID: NCT00772694
Status: UNKNOWN
Last Update Posted: 2008-10-24
First Post: 2008-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
Sponsor: Fondation Wygrajmy Zdrowie
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 12602
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: dr Iwona Skoneczna
Old Organization: Fondation Wygrajmy Zdrowie

Collaborators